(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol,
BMS 512148,
BMS-512148,
BMS512148,
dapagliflozin,
forxiga,
Dapagliflozin,
461432-26-8,
BMS-512148,
Forxiga,
Farxiga,
BMS 512148,
UNII-1ULL0QJ8UC,
BMS512148,
1ULL0QJ8UC,
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol,
CHEMBL429910,
CHEBI:85078,
Dapagliflozin [USAN:INN],
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
Forxiga (TN),
CHEMBL3125458,
(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol,
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-,
(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol,
(1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-D-glucitol,
D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-,
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol,
AK161692,
S1548_Selleck,
C-aryl glucoside, 6,
PubChem22435,
Tube101,
960404-48-2,
Dapagliflozin (USAN/INN),
2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol,
SCHEMBL157820,
GLU006,
GTPL4594,
BDBM20880,
EX-A005,
JVHXJTBJCFBINQ-ADAARDCZSA-N,
BCPP000265,
AMX10145,
AOB87300,
KS-000006UW,
ZINC3819138,
AN-431,
BDBM50448923,
CD0219,
MFCD13182359,
s1548,
AKOS005145763,
API0007667,
BCP9000583,
BMS5121458,
CCG-229917,
CS-0781,
DB06292,
EX-7214,
PB11055,
RL03723,
AC-24699,
AJ-45726,
HY-10450,
SC-25116,
AB1008441,
AX8161909,
FT-0665469,
ST24046416,
A25150,
D08897,
Q-3845,
432D268,
J-500392,
BRD-K58160573-001-01-3,
BRD-K58160573-001-05-4,
BMS-512148, 461432-26-8,
1-[3-(beta-D-Glucopyranosyl)-6-chlorobenzyl]-4-ethoxybenzene,
(2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol,
(2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol;BMS-512148,
(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol,
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol,
dapaglifozin,
Dapagliflozin [USAN],
Dapagliflozin propanediol,
D01TNW,
Dapagliflozin (INN/USAN),
cc-205,
Dapagliflozin/BMS-512148,
BMS-512148, Dapagliflozin,
CHEMBL3125316,
CHEMBL3125317,
CHEMBL3125318,
CHEMBL3125455,
CHEMBL3125456,
CHEMBL3125457,
dapagliflozin propanediol monohydrate,
ACN-028597,
CID9887712,
CS-O-11248,
Dapagliflozin propylene glycolate hydrate,
BMS-512148-05,
A5854,
A10285,
C529054,
(2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol,
(2S,4R,5R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol,